A Study of DF6002 Alone and in Combination With Nivolumab
Dragonfly Therapeutics
Dragonfly Therapeutics
Dragonfly Therapeutics
Seagen Inc.
Emory University
Endeavor Biomedicines, Inc.
Pharmassist Ltd
Abramson Cancer Center at Penn Medicine
Bayer
Virginia Commonwealth University
Merck Sharp & Dohme LLC
Arcus Biosciences, Inc.
Mayo Clinic
Incyte Corporation
Hoffmann-La Roche
Palleon Pharmaceuticals, Inc.
Incyte Corporation
Incyte Corporation
MacroGenics
Yale University
Genentech, Inc.
Biogen
NGM Biopharmaceuticals, Inc
Thomas Jefferson University
Scholar Rock, Inc.
National Institutes of Health Clinical Center (CC)
Revolution Medicines, Inc.
Tvardi Therapeutics, Incorporated
Syndax Pharmaceuticals
Labcorp Corporation of America Holdings, Inc
University Medical Center Groningen
BerGenBio ASA
Stanford University
BioAtla, Inc.
Purple Biotech Ltd.
Eli Lilly and Company
AstraZeneca
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
GlaxoSmithKline
Mayo Clinic
Natera, Inc.
National Cancer Institute (NCI)
Xencor, Inc.
Centre hospitalier de l'Université de Montréal (CHUM)
National Institutes of Health Clinical Center (CC)
Bristol-Myers Squibb
University of Southern California
Cedars-Sinai Medical Center
University Medical Center Groningen
University Medical Center Groningen
Exelixis